← Fluticasone/Mupirocin

Patient counseling sheet

Print-ready and generated without storing patient details.

AfyaIndex · counseling handout

Fluticasone/Mupirocin

Corticosteroid

Prepared 19 Sep 2026

What it is used for

Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing Clinical selection for Fluticasone/Mupirocin should follow culture results where relevant, Kenya STG/EML recommendations, and the current product SmPC. Class context: Corticosteroid. Confirm site-specific dose, duration and monitoring before prescribing.

Warnings

Shortest course, lowest dose. Taper after prolonged systemic use. Infection risk, hyperglycaemia, BP rise, mood changes, osteoporosis, avascular necrosis, glaucoma/cataract. Adrenal insufficiency on withdrawal. Stress-dose cover if indicated.

Possible side effects

[From component Fluticasone Propionate (skin)] Local irritation e.g burning sensation and itching, erythema rare, dryness of the skin, aggravation of concurrent untreated infections, thinning of the skin (this may be reversible), loss of skin elasticity, folliculitis, change in skin pigmentation, telangiectasia, purpura and steroid acne, increased growth of hair, severe pituitary-adrenal axis suppression and hypercotism, cushoid state, growth retardation, benign intra-cranial hypertension.

Storage

Store as labelled. Keep out of reach of children.

No reviewed patient-education article is available. The fields shown are from the currently verified medicine record and unavailable fields are not inferred.

AfyaIndex dataset coverage